Medicube Lands in 1,300 Shoppers Drug Mart Stores Across Canada

South Korea's APR has placed 13 Medicube skincare products on shelves in roughly 1,300 Shoppers Drug Mart stores, a nationwide Canadian rollout that moves the brand decisively beyond its ecommerce base. Shoppers Drug Mart is Canada's largest drugstore chain and a subsidiary of the grocery and pharmacy group Loblaw. The move signals that K-Beauty brands now treat physical retail partnerships, not online storefronts alone, as the engine of North American scale.

Which products are in the rollout?

The assortment spans Medicube's best-known actives-led formats. The range includes:

• Zero Pore Pad, an exfoliating toner pad built around pore-refining acids
• PDRN Pink Peptide Ampoule, a serum formulated with PDRN (polydeoxyribonucleotide, a salmon-DNA-derived ingredient popular in Korean aesthetic skincare)
• PDRN Pink Collagen Gel Mask
• Deep Vita C Capsule Cream, a vitamin C delivery format

APR has not committed to a fixed assortment. The company plans to expand the lineup according to local demand and sales performance, which leaves the depth of the rollout dependent on early sell-through data rather than a pre-set calendar.

How strong is the underlying demand?

The distribution deal rests on measurable momentum. NielsenIQ data show Canadian sales of Korean cosmetics rose 57 percent last year to US$164 million. That growth rate, sustained across a full market rather than a single brand's channel, explains why a major drugstore chain would allocate shelf space to a relatively young Korean label.

Digital traction reinforces the case. Six Medicube products ranked among Amazon Canada's top 100 facial skincare bestsellers in early November. Bestseller rankings are snapshots, and Amazon's algorithm-driven lists fluctuate weekly; still, six simultaneous placements indicate consistent consumer pull rather than a single viral product.

What comes next?

Costco Canada is the next target. APR is preparing to launch Medicube through the warehouse chain, extending physical retail presence beyond drugstore distribution. A drugstore-to-warehouse-club sequence is a deliberate one: Shoppers Drug Mart reaches mass and premium skincare shoppers in urban centers, while Costco delivers volume through bulk formats and a suburban membership base.

The strategy also reduces a structural vulnerability. Brands built primarily on ecommerce face rising digital advertising costs and platform dependence; brick-and-mortar distribution diversifies revenue and puts products in front of consumers who never encounter them online. APR's own framing, reported by The Korea Times, emphasizes that securing nationwide distribution strengthens Medicube's market penetration and reduces reliance on ecommerce.

What is not yet known?

The announcement leaves several questions open. APR has not disclosed wholesale terms, retail pricing tiers for the Canadian shelf, or marketing support commitments from Shoppers Drug Mart. Nor has the company published sales figures for its existing North American channels, making it impossible to gauge what share of revenue the new physical footprint might represent.

Competition is the other untested variable. Canada's mass and premium skincare sectors already host established dermocosmetic and pharmaceutical brands with loyal followings. Medicube's ingredient-led positioning, particularly its PDRN line, overlaps with the growing "skin-identical" and aesthetic-adjacent categories those incumbents are also chasing.

For dermatology professionals, the expansion matters as a distribution signal: Korean cosmeceutical brands with clinical-adjacent ingredient stories are now reaching Canadian patients through mainstream pharmacy shelves, where no professional gatekeeping governs product selection. Whether sustained demand follows the 57 percent market growth, or whether the shelf space outpaces it, will become visible in APR's assortment decisions and the pace of the Costco launch over the coming quarters.